Into the Unknown: Methodological and Ethical Issues in Phase I Trials

by

MUHCtalk

Tuesday, April 18, 2017
12:00 – 1:00pm
RI auditorium, Glen Site – E S1.1129

With the current push to transform Montréal into a hub for early phase research, there is a pressing need to explore the issues that researchers and research ethics boards (REB) encounter in Phase I trials.

In this two-part presentation, recent examples from healthy volunteer and oncology studies will be used to illustrate how protocol design and ethics review can be enhanced.

BibTeX

@Manual{stream2017-1252,
    title = {Into the Unknown: Methodological and Ethical Issues in Phase I Trials},
    journal = {STREAM research},
    author = {Esther Vinarov},
    address = {Montreal, Canada},
    date = 2017,
    month = apr,
    day = 17,
    url = {http://www.translationalethics.com/2017/04/17/into-the-unknown-methodological-and-ethical-issues-in-phase-i-trials/}
}

MLA

Esther Vinarov. "Into the Unknown: Methodological and Ethical Issues in Phase I Trials" Web blog post. STREAM research. 17 Apr 2017. Web. 25 May 2019. <http://www.translationalethics.com/2017/04/17/into-the-unknown-methodological-and-ethical-issues-in-phase-i-trials/>

APA

Esther Vinarov. (2017, Apr 17). Into the Unknown: Methodological and Ethical Issues in Phase I Trials [Web log post]. Retrieved from http://www.translationalethics.com/2017/04/17/into-the-unknown-methodological-and-ethical-issues-in-phase-i-trials/


Who Cares if the Emperor is Immodestly Attired: An Exploration of the Trustworthiness of Biomedical Research

by

caesar

Tuesday, October 4, 2016
1 PM
3647 Peel St., Room 101

Everyone acknowledges the need for biomedical research to enjoy the public’s trust that it continuously solicits and receives. An ethical precondition of soliciting trust is knowing the extent to which that trust is deserved. What makes biomedical research deserving of the public trust requires in-depth attention. This session will review three different criteria of trustworthiness in research – reliability, social value, and ethical conduct – to explore the extent to which the biomedical research enterprise warrants public trust.

Mark Yarborough, PhD, is Professor of General Medicine and Geriatrics and Dean’s Professor of Bioethics in the Bioethics Program at the University of California, Davis.

Photo by clarita

BibTeX

@Manual{stream2016-1149,
    title = {Who Cares if the Emperor is Immodestly Attired: An Exploration of the Trustworthiness of Biomedical Research},
    journal = {STREAM research},
    author = {Esther Vinarov},
    address = {Montreal, Canada},
    date = 2016,
    month = sep,
    day = 12,
    url = {http://www.translationalethics.com/2016/09/12/stream-workshop-series-2016-october-4th-mark-yarborough/}
}

MLA

Esther Vinarov. "Who Cares if the Emperor is Immodestly Attired: An Exploration of the Trustworthiness of Biomedical Research" Web blog post. STREAM research. 12 Sep 2016. Web. 25 May 2019. <http://www.translationalethics.com/2016/09/12/stream-workshop-series-2016-october-4th-mark-yarborough/>

APA

Esther Vinarov. (2016, Sep 12). Who Cares if the Emperor is Immodestly Attired: An Exploration of the Trustworthiness of Biomedical Research [Web log post]. Retrieved from http://www.translationalethics.com/2016/09/12/stream-workshop-series-2016-october-4th-mark-yarborough/


Search STREAM

Old blog posts


All content © STREAM research

admin@translationalethics.com
Twitter: @stream_research
3647 rue Peel
Montreal QC H3A 1X1